Blue Oak Pharmaceuticals
Concord, US · Founded 2016 · Delaware corporation
Founders & leadership
TH
Thomas H. LargeNamed on SEC filing
KL
Kerry Leigh SpearNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2020
▶$1.8MraisedFeb 2020 · 2 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedFeb 2020 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas H. LargeExecutive Officer, Director
- Kerry Leigh SpearDirector
- Offering amount
- $9M
- Amount sold
- $1.8M
- Proceeds to insiders
- $125K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Blue Oak Pharmaceuticals raised?
- Blue Oak Pharmaceuticals has disclosed $1.8M raised across 1 round.
- Where is Blue Oak Pharmaceuticals headquartered?
- Blue Oak Pharmaceuticals is headquartered in Concord, US.